These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2530288)

  • 1. Intradermal hepatitis B vaccination for mentally retarded patients.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W
    J Infect; 1989 Sep; 19(2):119-25. PubMed ID: 2530288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped.
    Hayashi J; Nakashima K; Noguchi A; Morofuji M; Kashiwagi S
    J Infect; 1991 Jul; 23(1):39-45. PubMed ID: 1832182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunogenicity of the vaccine against the HBV in the mentally retarded].
    Cobo Soriano J; Gil Miguel A; Rey Calero J; Herrazo Cabrera R; Martín Hernández D
    Aten Primaria; 1991; 8(7):536, 538-40, 542. PubMed ID: 1836394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P; Vranckx R; Meheus A
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trials of intradermal hepatitis B vaccines in Gambian children.
    Whittle HC; Lamb WH; Ryder RW
    Ann Trop Paediatr; 1987 Mar; 7(1):6-9. PubMed ID: 2439007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].
    García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI
    Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related response to hepatitis B vaccine in the mentally retarded.
    Torre D; Maggiolo F; Broggini M; Botta V
    Lancet; 1984 Oct; 2(8407):866. PubMed ID: 6148591
    [No Abstract]   [Full Text] [Related]  

  • 11. Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age.
    Morris CA; Oliver PR; Reynolds F; Selkon JB
    Epidemiol Infect; 1989 Oct; 103(2):387-94. PubMed ID: 2530104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to hepatitis B vaccine in the mentally retarded.
    Wahl M; Hermodsson S; Iwarson S
    J Infect; 1983 Jul; 7 Suppl 1():47-51. PubMed ID: 6232324
    [No Abstract]   [Full Text] [Related]  

  • 13. Intradermal hepatitis B virus vaccination for low- or non-responded health-care workers.
    Yasumura S; Shimizu Y; Yasuyama T; Hiroki O; Okada K; Tsukishiro T; Tsuchida T; Higuchi K; Watanabe A
    Acta Med Okayama; 1991 Dec; 45(6):457-9. PubMed ID: 1838229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].
    García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J
    Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.
    Mok Q; Underhill G; Wonke B; Aldouri M; Kelsey M; Jefferies D
    Arch Dis Child; 1989 Apr; 64(4):535-40. PubMed ID: 2526622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenicity and safety of intradermal hepatitis B vaccine.
    Toffler WL; Olenick JS; Wolf NE; Retzlaff ZH; Swanson JR; Kenny TA
    J Fam Pract; 1991 Aug; 33(2):149-54. PubMed ID: 1832438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results.
    Ayoola EA; Atoba MA; Johnson AO
    Arch Virol; 1986; 91(3-4):291-6. PubMed ID: 2946277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines.
    Troisi CL; Heiberg DA; Hollinger FB
    JAMA; 1985 Dec; 254(22):3196-9. PubMed ID: 2933533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-efficacy of low-dose intradermal vaccination against hepatitis B in Down's syndrome.
    Ahman L; Bäck E; Bensch K; Olcén P
    Scand J Infect Dis; 1993; 25(1):16-23. PubMed ID: 8460344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines.
    Bryan JP; Sjogren M; Iqbal M; Khattak AR; Nabi S; Ahmed A; Cox B; Morton A; Shuck J; Macarthy P
    J Infect Dis; 1990 Oct; 162(4):789-93. PubMed ID: 2144866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.